Live Oak Private Wealth’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
PCM
NIM
FHA
AAM
1WA
Live Oak Private Wealth's HQL Position: Q2 2026 in Review
Live Oak Private Wealth held its abrdn Life Sciences Investors (HQL) position steady in Q2 2026 at 13,223 shares worth $265K. The position accounts for 0.03% of the portfolio, ranked #184.
Live Oak Private Wealth first reported a position in HQL in Q2 2020 and has held it in 25 quarters since. The position peaked at $284K in Q2 2021. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- Live Oak Private Wealth held 13,223 shares of abrdn Life Sciences Investors worth $265K as of Q2 2026.
- Live Oak Private Wealth left its abrdn Life Sciences Investors share count unchanged in Q2 2026.
- abrdn Life Sciences Investors made up 0.03% of Live Oak Private Wealth's portfolio in Q2 2026, its #184 holding.
- Live Oak Private Wealth first reported a position in abrdn Life Sciences Investors in Q2 2020 and has held it in 25 quarters since.
- Live Oak Private Wealth's abrdn Life Sciences Investors position peaked at $284K in Q2 2021.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on Live Oak Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.